Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: Malaysia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20131
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Viatris Innovation GmbH2
Anthera Pharmaceuticals1
AstraZeneca1
Eli Lilly and Company1
Human Genome Sciences Inc., a GSK Company1
Novartis Pharmaceuticals1
Pfizer1
X4 Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases9
Immune System Diseases5
Lupus Erythematosus, Systemic5
Connective Tissue Diseases3
Arthritis, Rheumatoid1
Barth Syndrome1
Female Urogenital Diseases1
Female Urogenital Diseases and Pregnancy Complications1
Glomerulonephritis1
Glomerulonephritis, IGA1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.